other Trials
Drug Intervention Trials that are Recruiting
Study Title
Investigators
Disease Categories
Maarten G Lansberg MD, PhD
Gregory W Albers
Neil Schwartz
Christine Wijman
Anna K. Finley Caulfield
Dr. chitra venkat
Archana Purushotham
Edgar Samaniego
Mikayel Grigoryan
Duane Omar Campbell
Gregory W Albers
Neil Schwartz
Christine Wijman
Anna K. Finley Caulfield
Dr. chitra venkat
Archana Purushotham
Edgar Samaniego
Mikayel Grigoryan
Duane Omar Campbell
Cerebrovascular Accident
Christine Wijman
Gregory W Albers
Anna K. Finley Caulfield
Maarten G Lansberg MD, PhD
Neil Schwartz
Dr. chitra venkat
Dr Marion S Buckwalter
Steven Daniel Chang
Robert Dodd
Archana Purushotham
Jean-Marc Olivot
Duane Omar Campbell
Edgar Samaniego
Mikayel Grigoryan
Gregory W Albers
Anna K. Finley Caulfield
Maarten G Lansberg MD, PhD
Neil Schwartz
Dr. chitra venkat
Dr Marion S Buckwalter
Steven Daniel Chang
Robert Dodd
Archana Purushotham
Jean-Marc Olivot
Duane Omar Campbell
Edgar Samaniego
Mikayel Grigoryan
Cerebral Hemorrhage
James Victor Quinn
Gregory W Albers
Gregory W Albers
Cerebrovascular Accident
James Victor Quinn
Seizures
Device Intervention Trials that are Recruiting
Study Title
Investigators
Disease Categories
Terence D. Sanger
Dystonia
Other Trials that are Recruiting
Study Title
Investigators
Disease Categories
Kathleen L Poston
Helen M. Bronte-Stewart
Dr Jaimie Henderson
Pravin Khemani
Helen M. Bronte-Stewart
Dr Jaimie Henderson
Pravin Khemani
Parkinson Disease
Trials not Recruiting
Study Title
Investigators
Disease Categories
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two (CARE-MS II)
(No longer recruiting)
Jeffrey E. Dunn
Multiple Sclerosis, Relapsing-Remitting
Oral Cladribine in Early Multiple Sclerosis (MS) (ORACLE MS)
(Not yet recruiting)
Jeffrey E. Dunn
Multiple Sclerosis
